tiprankstipranks
Trending News
More News >
Medifast (MED)
:MED
US Market
Advertisement

Medifast (MED) Earnings Dates, Call Summary & Reports

Compare
1,240 Followers

Earnings Data

Report Date
Feb 24, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.82
Last Year’s EPS
0.1
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 03, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call presented a balanced view of challenges and progress. While Medifast highlighted significant achievements in clinical research and a strong financial position, the company also faced substantial revenue declines and a decrease in active coaches. Despite the challenges, the company is optimistic about new product launches and strategic programs to stabilize and grow in the future.
Company Guidance
During the Medifast Third Quarter 2025 earnings call, the company provided guidance reflecting a strategic pivot towards addressing metabolic health rather than just weight loss. Revenue for the quarter was reported at $89 million, aligning with the high end of guidance, while EPS was within the projected range. The company highlighted the retention of 98% of lean mass in clients on their program over 16 weeks, alongside a 14% reduction in visceral fat. Despite a 36.2% decline in revenue year-over-year, Medifast emphasized the stability in active coach productivity, which showed only a 2% year-over-year decline to $4,585. Looking forward, Medifast expects fourth-quarter revenue to range from $65 million to $80 million, with a loss per share between $0.70 and $1.25. The company is also preparing to introduce a new product line in 2026, leveraging their metabolic synchronization science to further differentiate in the market.
Clinical Research Findings
Medifast announced clinical research findings demonstrating that their program retains 98% of lean mass, reduces visceral fat by 14%, and improves body composition while losing weight.
Strong Financial Position
Medifast maintains a strong balance sheet with $173.5 million in cash, cash equivalents, and investments, and no interest-bearing debt.
New Product Line Announcement
A new product line using metabolic synchronization science and next-generation ingredients for metabolic enhancement is expected to launch next year.
Initial Positive Response to Premier+ Program
The Premier+ pricing and auto ship program has shown an uptick in baseline client retention beyond the first month.

Medifast (MED) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

MED Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 24, 2026
2025 (Q4)
-0.82 / -
0.1
Nov 03, 2025
2025 (Q3)
-0.36 / -0.21
0.35-160.00% (-0.56)
Aug 04, 2025
2025 (Q2)
-0.19 / 0.40
0.92-56.41% (-0.52)
Apr 28, 2025
2025 (Q1)
-0.25 / -0.03
0.66-105.00% (-0.69)
Feb 18, 2025
2024 (Q4)
-0.15 / 0.10
1.09-90.83% (-0.99)
Nov 04, 2024
2024 (Q3)
-0.19 / 0.35
2.12-83.49% (-1.77)
Aug 05, 2024
2024 (Q2)
0.39 / 0.92
2.77-66.79% (-1.85)
Apr 29, 2024
2024 (Q1)
0.80 / 0.66
3.67-82.02% (-3.01)
Feb 20, 2024
2023 (Q4)
0.96 / 1.09
3.7-70.54% (-2.61)
Nov 06, 2023
2023 (Q3)
1.06 / 2.12
3.32-36.14% (-1.20)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

MED Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 03, 2025
$11.88$11.98+0.84%
Aug 04, 2025
$13.51$13.07-3.26%
Apr 28, 2025
$12.58$12.50-0.64%
Feb 18, 2025
$16.13$14.29-11.41%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Medifast (MED) report earnings?
Medifast (MED) is schdueled to report earning on Feb 24, 2026, After Close (Confirmed).
    What is Medifast (MED) earnings time?
    Medifast (MED) earnings time is at Feb 24, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is MED EPS forecast?
          MED EPS forecast for the fiscal quarter 2025 (Q4) is -0.82.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis